PLSE - Rasio utang marang kapitalisasi buku Pulse Biosciences Inc

Logo korporat perusahaan Pulse Biosciences, Inc. (PLSE)

This daily price chart for Pulse Biosciences, Inc. (PLSE), which is currently trading at 0.07, illustrates the company's market trend. The team relies on a staff of experienced designers, strategically recruiting certification and testing specialists. Business stability is constrained by medical trial outcomes and product launch costs. Revenue is generated through the supply of devices to dermatologists for the gentle removal of skin neoplasms.

Pulse Biosciences, Inc. - Utang-utang marang kapitalisasi buku PLSE (periode 04.07.2022 - 27.10.2026)
Barang unggulan Pulse Medical

To objectively evaluate Pulse Biosciences, Inc. (PLSE), it is necessary to analyze the ratio of total credit obligations to net equity. This balance sheet financial leverage demonstrates the company's degree of dependence on borrowed funds, which is critical for a startup that must validate its technological efficacy through FDA approval and product commercialization under the strict supervision of key shareholders.

Pesaing Pulse Biosciences, Inc.

DXCM: Utang-utang marang kapitalisasi buku|penumbrainc.com - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Novanta (NOVT)|HAE - Rasio utang marang aset resik|INSP: Utang-utang marang kapitalisasi buku|PRCT (Procept) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CONMED Corporation CNMD|Rasio utang-utang marang kapitalisasi buku inmodemd.com|Picard Medical - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Surmodics Inc SRDX|Utang marang nilai buku SENS (senseonics.com)|NPCE - Utang-utang marang kapitalisasi buku|Utang marang nilai buku Tactile Systems Technology Inc. TCMD|SNWV - Utang marang modal buku|Outset Medical - Utang-utang marang kapitalisasi buku|Electromed (ELMD) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku LNSR|Utang marang nilai buku AVITA Medical Inc (RCEL)|Profound Medical Corp. (PROF) - Utang marang nilai buku|Rasio utang marang aset resik BDMD (bairdmed.com)|EDAP TMS - Rasio utang marang kapitalisasi buku|Utang marang nilai buku Apyx Medical Corp APYX|ICCM (IceCure Medical, Ltd.) - Utang-utang marang kapitalisasi buku|LUNG - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku telabio.com|CytoSorbents Corporation (CTSO) - Rasio utang marang nilai buku|SRTS: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Zynex Medical|Utang-utang marang kapitalisasi buku ECOR (electroCore, Inc.)|Utang marang nilai buku vicarioussurgical.com (RBOT)|Utang-utang marang kapitalisasi buku IINN (Inspira Technologies)|seastarmedical.com - Utang-utang marang kapitalisasi buku|IRIX - Rasio utang marang kapitalisasi buku|Intelligent Bio Solutions (INBS) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku beyondair.net XAIR|Profusa, Inc (PFSA) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku SSKN (STRATA Skin Sciences Inc.)|Utang-utang marang nilai buku GCTK|NAOV: Rasio utang marang kapitalisasi buku|Utang marang aset resik Venus Concept Inc VERO|Utang marang nilai buku NUWE (CHF Solutions)|Utang-utang marang kapitalisasi buku Aethlon Medical Corp AEMD|Utang-utang marang kapitalisasi buku ASXC (TransEnterix)|AVGR: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku KNW|Utang marang nilai buku Inari Medical Corp|Nevro Corp. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku RSLS (reshapelifesciences.com)|SILK - Rasio utang marang kapitalisasi buku